These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23632342)

  • 1. The role of imaging in hepatocellular carcinoma: the present and future.
    Davarpanah AH; Weinreb JC
    J Clin Gastroenterol; 2013 Jul; 47 Suppl():S7-10. PubMed ID: 23632342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatocellular carcinoma: newer radiological tools.
    Lee JM; Yoon JH; Kim KW
    Semin Oncol; 2012 Aug; 39(4):399-409. PubMed ID: 22846858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances of imaging for hepatocellular carcinoma.
    Choi BI
    Oncology; 2010 Jul; 78 Suppl 1():46-52. PubMed ID: 20616584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and MR imaging of hepatocellular carcinoma.
    Bolog N; Andreisek G; Oancea I; Mangrau A
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):181-9. PubMed ID: 21725516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT and MRI of hepatocellular carcinoma: an update.
    Ayyappan AP; Jhaveri KS
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D; Di Martino M; Guerrisi A; De Filippis G; Rossi M; Ginanni Corradini S; Masciangelo R; Catalano C; Passariello R
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
    Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
    Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic diagnosis of hepatocellular carcinoma.
    Ishiguchi T; Shimamoto K; Fukatsu H; Yamakawa K; Ishigaki T
    Semin Surg Oncol; 1996; 12(3):164-9. PubMed ID: 8727605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of imaging diagnosis of hepatocellular carcinoma.
    Choi BI
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S20-5. PubMed ID: 14762834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S; Matsui O; Kamura T; Yamamoto S; Yoneda N; Gabata T; Terayama N; Sanada J
    J Comput Assist Tomogr; 2007; 31(4):557-63. PubMed ID: 17882031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of HCC.
    Ayuso C; Rimola J; García-Criado A
    Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of hepatocellular carcinoma and early diagnosis.
    Limaye AR; Cabrera R
    Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.